{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:15:06Z","timestamp":1787505306122,"version":"build-2736575974"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00702-025-02932-0","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T13:57:33Z","timestamp":1746453453000},"page":"999-1011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic potential of COX-2 inhibitors in neuropsychiatric disorders"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-2012","authenticated-orcid":false,"given":"Veerta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3656-669X","authenticated-orcid":false,"given":"Prateek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"1\u20133","key":"2932_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","volume":"90","author":"S Akhondzadeh","year":"2007","unstructured":"Akhondzadeh S, Tabatabaee M, Amini H, Abhari SAA, Abbasi SH, Behnam B (2007) Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res 90(1\u20133):179\u2013185","journal-title":"Schizophr Res"},{"issue":"3","key":"2932_CR2","first-page":"164","volume":"4","author":"M Al-Alawi","year":"2018","unstructured":"Al-Alawi M, Al Sinawi H, Rashid R (2018) In the realm of psychoneuroimmunology: the role of celecoxib as an add-on treatment for bipolar mania. Mol Neuropsychiatry 4(3):164\u2013167","journal-title":"Mol Neuropsychiatry"},{"key":"2932_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-323-99855-0.00004-X","volume-title":"How synthetic drugs work","author":"KA Ali","year":"2023","unstructured":"Ali KA, Maity A, Roy SD, Pramanik SD, Das PP, Shaharyar MA (2023) Insight into the mechanism of steroidal and non-steroidal anti-inflammatory drugs. How synthetic drugs work. Academic Press, New York, pp 61\u201394"},{"key":"2932_CR108","doi-asserted-by":"crossref","unstructured":"Andoh M, Ikegaya Y, Koyama R (2019) Synaptic pruning by microglia in epilepsy. J Clin Med 8(12):2170","DOI":"10.3390\/jcm8122170"},{"issue":"6","key":"2932_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bdi.12324","volume":"17","author":"S Arabzadeh","year":"2015","unstructured":"Arabzadeh S, Ameli N, Zeinoddini A, Rezaei F, Farokhnia M, Mohammadinejad P, Akhondzadeh S (2015) Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial. Bipolar Disord. 17(6):606\u2013614","journal-title":"Bipolar Disord."},{"issue":"8","key":"2932_CR5","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/jcm13082190","volume":"13","author":"V Baglioni","year":"2024","unstructured":"Baglioni V, Bozza F, Lentini G, Beatrice A, Cameli N, ColacinoCinnante EM, Pisani F (2024) Psychiatric manifestations in children and adolescents with inherited metabolic diseases. J Clin Med 13(8):2190","journal-title":"J Clin Med"},{"key":"2932_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jpsychires.2016.07.007","volume":"81","author":"F Bartoli","year":"2016","unstructured":"Bartoli F, Crocamo C, Mazza MG, Clerici M, Carra G (2016) Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis. J Psychiatr Res 81:133\u2013139","journal-title":"J Psychiatr Res"},{"issue":"1","key":"2932_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nyas.13712","volume":"1437","author":"ME Bauer","year":"2019","unstructured":"Bauer ME, Teixeira AL (2019) Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci 1437(1):57\u201367","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2932_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1871527317666181105162347","volume":"18","author":"DV Bavaresco","year":"2019","unstructured":"Bavaresco DV, Colonetti T, Grande AJ, Colom F, Valvassori SS, Quevedo J, da Rosa MI (2019) Efficacy of celecoxib adjunct treatment on bipolar disorder: systematic review and meta-analysis. CNS & Neurol Disord-Drug Targets. 18(1):19\u201328","journal-title":"CNS & Neurol Disord-Drug Targets."},{"issue":"5","key":"2932_CR9","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1042\/BST0371104","volume":"37","author":"RP Bazinet","year":"2009","unstructured":"Bazinet RP (2009) Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? Biochem Soc Trans 37(5):1104\u20131109","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2932_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11011-022-01095-1","volume":"38","author":"S Bhatt","year":"2023","unstructured":"Bhatt S, Devadoss T, Jha NK, Baidya M, Gupta G, Chellappan DK, Dua K (2023) Targeting inflammation: a potential approach for the treatment of depression. Metab Brain Dis 38(1):45\u201359","journal-title":"Metab Brain Dis"},{"key":"2932_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2017.07.002","volume":"299","author":"SD Bilbo","year":"2018","unstructured":"Bilbo SD, Block CL, Bolton JL, Hanamsagar R, Tran PK (2018) Beyond infection-Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol 299:241\u2013251","journal-title":"Exp Neurol"},{"key":"2932_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-4-3","volume":"4","author":"M Boris","year":"2007","unstructured":"Boris M, Kaiser CC, Goldblatt A, Elice MW, Edelson SM, Adams JB, Feinstein DL (2007) Effect of pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation 4:1\u20137","journal-title":"J Neuroinflammation"},{"issue":"5","key":"2932_CR13","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00431-022-04407-w","volume":"181","author":"J Cendejas-Hernandez","year":"2022","unstructured":"Cendejas-Hernandez J, Sarafian JT, Lawton VG, Palkar A, Anderson LG, Larivi\u00e8re V, Parker W (2022) Paracetamol (acetaminophen) use in infants and children was never shown to be safe for neurodevelopment: a systematic review with citation tracking. Eur J Pediatr 181(5):1835\u20131857","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2932_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ars.2020.8076","volume":"33","author":"C Cervellati","year":"2020","unstructured":"Cervellati C, Trentini A, Pecorelli A, Valacchi G (2020) Inflammation in neurological disorders: the thin boundary between brain and periphery. Antioxid Redox Signal 33(3):191\u2013210","journal-title":"Antioxid Redox Signal"},{"issue":"2\u20133","key":"2932_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000346157","volume":"35","author":"LJ Chew","year":"2013","unstructured":"Chew LJ, Fusar-Poli P, Schmitz T (2013) Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci 35(2\u20133):102\u2013129","journal-title":"Dev Neurosci"},{"key":"2932_CR109","doi-asserted-by":"crossref","unstructured":"Chiang CW, Wang Y, Sun P, Lin TH, Trinkaus K, Cross AH, Song SK (2014) Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema. Neuroimage 101:310\u2013319","DOI":"10.1016\/j.neuroimage.2014.06.064"},{"issue":"10","key":"2932_CR16","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176161","volume":"50","author":"XZ Dong","year":"2017","unstructured":"Dong XZ, Wang DX, Lu YP, Yuan S, Liu P, Hu Y (2017) Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats. Braz J Med Biol Res 50(10):e6161","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"2932_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","volume":"89","author":"A Ebersberger","year":"1999","unstructured":"Ebersberger A, Averbeck B, Messlinger K, Reeh PW (1999) Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89(3):901\u2013907","journal-title":"Neuroscience"},{"key":"2932_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2018.02.004","volume":"102","author":"D Edberg","year":"2018","unstructured":"Edberg D, Hoppensteadt D, Walborn A, Fareed J, Sinacore J, Halaris A (2018) Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. J Psychiatr Res 102:1\u20137","journal-title":"J Psychiatr Res"},{"issue":"18","key":"2932_CR19","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.2174\/0929867325666180514112124","volume":"26","author":"MD Ferrer","year":"2019","unstructured":"Ferrer MD, Busquets-Cort\u00e9s C, Cap\u00f3 X, Tejada S, Tur JA, Pons A, Sureda A (2019) Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases. Curr Med Chem 26(18):3225\u20133241","journal-title":"Curr Med Chem"},{"issue":"10","key":"2932_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","volume":"73","author":"AM Fineberg","year":"2013","unstructured":"Fineberg AM, Ellman LM (2013) Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiat 73(10):951\u2013966","journal-title":"Biol Psychiat"},{"issue":"1","key":"2932_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/npp.2016.125","volume":"42","author":"M Fleshner","year":"2017","unstructured":"Fleshner M, Frank M, Maier SF (2017) Danger signals and inflammasomes: stress-evoked sterile inflammation in mood disorders. Neuropsychopharmacology 42(1):36\u201345","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2932_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/187152711794653751","volume":"10","author":"AK Frankola","year":"2011","unstructured":"Frankola AK, Greig NH, Luo W, Tweedie D (2011) Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord-Drug Targets 10(3):391\u2013403","journal-title":"CNS Neurol Disord-Drug Targets"},{"issue":"3","key":"2932_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jad.2012.01.016","volume":"138","author":"P Ga\u0142ecki","year":"2012","unstructured":"Ga\u0142ecki P, Ga\u0142ecka E, Maes M, Chamielec M, Orzechowska A, Bobi\u0144ska K, Szemraj J (2012) The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord 138(3):360\u2013366","journal-title":"J Affect Disord"},{"key":"2932_CR24","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1007\/s12035-017-0822-x","volume":"55","author":"D G\u0142adysz","year":"2018","unstructured":"G\u0142adysz D, Krzywdzi\u0144ska A, Hozyasz KK (2018) Immune abnormalities in autism spectrum disorder\u2014could they hold promise for causative treatment? Mol Neurobiol 55:6387\u20136435","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2932_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"issue":"2","key":"2932_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/1871527320666210208130412","volume":"21","author":"E Gorica","year":"2022","unstructured":"Gorica E, Calderone V (2022) Arachidonic acid derivatives and neuroinflammation. CNS & Neurol Disord-Drug Targets. 21(2):118\u2013129","journal-title":"CNS & Neurol Disord-Drug Targets."},{"issue":"2","key":"2932_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","volume":"50","author":"C Gunaydin","year":"2018","unstructured":"Gunaydin C, Bilge SS (2018) Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med 50(2):116","journal-title":"Eurasian J Med"},{"issue":"1","key":"2932_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tins.2017.10.006","volume":"41","author":"PJ Harrison","year":"2018","unstructured":"Harrison PJ, Geddes JR, Tunbridge EM (2018) The emerging neurobiology of bipolar disorder. Trends Neurosci 41(1):18\u201330","journal-title":"Trends Neurosci"},{"key":"2932_CR29","doi-asserted-by":"publisher","first-page":"1037588","DOI":"10.3389\/fpsyt.2022.1037588","volume":"13","author":"Y He","year":"2022","unstructured":"He Y, Han Y, Liao X, Zou M, Wang Y (2022) Biology of cyclooxygenase-2: an application in depression therapeutics. Front Psych 13:1037588","journal-title":"Front Psych"},{"key":"2932_CR30","doi-asserted-by":"publisher","first-page":"1361997","DOI":"10.3389\/fpsyt.2024.1361997","volume":"15","author":"Y Higuchi","year":"2024","unstructured":"Higuchi Y, Takahashi T, Itoh H, Sasabayashi D, Sumiyoshi T, Suzuki M (2024) Relationships between erythrocyte membrane mono-and poly-unsaturated fatty acid composition and clinical\/cognitive indices in antipsychotic-free schizophrenia patients. Front Psych 15:1361997","journal-title":"Front Psych"},{"issue":"4","key":"2932_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0271678X17733655","volume":"39","author":"J Hoffmann","year":"2019","unstructured":"Hoffmann J, Baca SM, Akerman S (2019) Neurovascular mechanisms of migraine and cluster headache. J Cereb Blood Flow Metab 39(4):573\u2013594","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2932_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gendis.2018.05.005","volume":"6","author":"D Huang","year":"2019","unstructured":"Huang D, Zhang L, Yang JQ, Luo Y, Cui T, Du TT, Jiang XH (2019) Evaluation on monoamine neurotransmitters changes in depression rats given with sertraline, meloxicam or\/and caffeic acid. Genes Dis 6(2):167\u2013175","journal-title":"Genes Dis"},{"issue":"5","key":"2932_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1159\/000335793","volume":"28","author":"C Huber","year":"2011","unstructured":"Huber C, Marschallinger J, Tempfer H, Furtner T, Couillard-Despres S, Bauer HC, Aigner L (2011) Inhibition of leukotriene receptors boosts neural progenitor proliferation. Cell Physiol Biochem. 28(5):793\u2013804","journal-title":"Cell Physiol Biochem."},{"issue":"2","key":"2932_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/08923973.2020.1728765","volume":"42","author":"DK Ingawale","year":"2020","unstructured":"Ingawale DK, Mandlik SK (2020) New insights into the novel anti-inflammatory mode of action of glucocorticoids. Immunopharmacol Immunotoxicol 42(2):59\u201373","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"2932_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2015.11.024","volume":"81","author":"JT Instanes","year":"2017","unstructured":"Instanes JT, Halm\u00f8y A, Engeland A, Haavik J, Furu K, Klungs\u00f8yr K (2017) Attention-deficit\/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biol Psychiat 81(5):452\u2013459","journal-title":"Biol Psychiat"},{"key":"2932_CR36","doi-asserted-by":"publisher","first-page":"1085950","DOI":"10.3389\/fendo.2023.1085950","volume":"14","author":"KA James","year":"2023","unstructured":"James KA, Stromin JI, Steenkamp N, Combrinck MI (2023) Understanding the relationships between physiological and psychosocial stress, cortisol and cognition. Front Endocrinol 14:1085950","journal-title":"Front Endocrinol"},{"issue":"6","key":"2932_CR37","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/sj.bjp.0704357","volume":"134","author":"DW Jenkins","year":"2001","unstructured":"Jenkins DW, Feniuk W, Humphrey PP (2001) Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol 134(6):1296\u20131302","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2932_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neulet.2004.05.067","volume":"366","author":"DW Jenkins","year":"2004","unstructured":"Jenkins DW, Langmead CJ, Parsons AA, Strijbos PJ (2004) Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro. Neurosci Lett 366(3):241\u2013244","journal-title":"Neurosci Lett"},{"issue":"11","key":"2932_CR39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1087054713510354","volume":"19","author":"N Joseph","year":"2015","unstructured":"Joseph N, Zhang-James Y, Perl A, Faraone SV (2015) Oxidative stress and ADHD: a meta-analysis. J Atten Disord 19(11):915\u2013924","journal-title":"J Atten Disord"},{"issue":"1","key":"2932_CR40","doi-asserted-by":"publisher","first-page":"9346470","DOI":"10.1155\/2016\/9346470","volume":"2016","author":"A Kaulmann","year":"2016","unstructured":"Kaulmann A, Bohn T (2016) Bioactivity of polyphenols: preventive and adjuvant strategies toward reducing inflammatory bowel diseases\u2014promises, perspectives, and pitfalls. Oxid Med Cell Longev 2016(1):9346470","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"2932_CR41","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0269881117711708","volume":"31","author":"P Kopschina Feltes","year":"2017","unstructured":"Kopschina Feltes P, Doorduin J, Klein HC, Ju\u00e1rez-Orozco LE, Dierckx RA, Moriguchi-Jeckel CM, de Vries EF (2017) Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol 31(9):1149\u20131165","journal-title":"J Psychopharmacol"},{"issue":"2","key":"2932_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1176\/appi.focus.18205","volume":"18","author":"C Kraus","year":"2020","unstructured":"Kraus C, Kadriu B, Lanzenberger R, Zarate CA Jr, Kasper S (2020) Prognosis and improved outcomes in major depression: a review. Focus 18(2):220\u2013235","journal-title":"Focus"},{"key":"2932_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","volume":"37","author":"KD Laxer","year":"2014","unstructured":"Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N, Benbadis SR (2014) The consequences of refractory epilepsy and its treatment. Epilepsy Behav 37:59\u201370","journal-title":"Epilepsy Behav"},{"key":"2932_CR107","doi-asserted-by":"crossref","unstructured":"Leffa DT, Panzenhagen AC, Rovaris DL, Bau CHD, Rohde LA, Grevet EH, Pires GN (2018) Behavioural effects of methylphenidate in the spontaneously hypertensive rat model of attention deficit\/hyperactivity disorder: a systematic review and meta-analysis protocol. BMJ Open Sci 2(1):e000001","DOI":"10.1136\/bmjos-2018-000001"},{"issue":"4","key":"2932_CR44","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1460-9568.2008.06068.x","volume":"27","author":"D Levy","year":"2008","unstructured":"Levy D, Zhang XC, Jakubowski M, Burstein R (2008) Sensitization of meningeal nociceptors: inhibition by naproxen. Eur J Neurosci 27(4):917\u2013922","journal-title":"Eur J Neurosci"},{"key":"2932_CR45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.neubiorev.2015.05.014","volume":"55","author":"JC Leza","year":"2015","unstructured":"Leza JC, Garc\u00eda-Bueno B, Bioque M, Arango C, Parellada M, Do K, Bernardo M (2015) Inflammation in schizophrenia: a question of balance. Neurosci Biobehav Rev 55:612\u2013626","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"2932_CR46","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/jama.2024.0851","volume":"331","author":"L Li","year":"2024","unstructured":"Li L, Zhu N, Zhang L, Kuja-Halkola R, D\u2019Onofrio BM, Brikell I, Chang Z (2024) ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA. 331(10):850\u2013860","journal-title":"JAMA."},{"issue":"9","key":"2932_CR47","first-page":"834","volume":"48","author":"CY Loo","year":"2007","unstructured":"Loo CY, Tan HJ, Teh HS, Raymond AA (2007) Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. Singapore Med J 48(9):834\u2013839","journal-title":"Singapore Med J"},{"issue":"12","key":"2932_CR48","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1007\/s12035-020-02087-x","volume":"57","author":"DE L\u00f3pez","year":"2020","unstructured":"L\u00f3pez DE, Ballaz SJ (2020) The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: neuronal homeostasis in memory and anxiety. Mol Neurobiol 57(12):5167\u20135176","journal-title":"Mol Neurobiol"},{"key":"2932_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbr.2017.04.053","volume":"330","author":"JL Lukkes","year":"2017","unstructured":"Lukkes JL, Meda S, Thompson BS, Freund N, Andersen SL (2017) Early life stress and later peer distress on depressive behavior in adolescent female rats: effects of a novel intervention on GABA and D2 receptors. Behav Brain Res 330:37\u201345","journal-title":"Behav Brain Res"},{"issue":"4","key":"2932_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11011-012-9326-6","volume":"27","author":"M Maes","year":"2012","unstructured":"Maes M (2012) Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression. Metab Brain Dis 27(4):405\u2013413","journal-title":"Metab Brain Dis"},{"issue":"5","key":"2932_CR51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/15622975.2019.1701203","volume":"21","author":"M Maes","year":"2020","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Carvalho AF (2020) In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde. World J Biol Psychiatry 21(5):383\u2013401","journal-title":"World J Biol Psychiatry"},{"issue":"5","key":"2932_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ana.20078","volume":"55","author":"Y Manabe","year":"2004","unstructured":"Manabe Y, Anrather J, Kawano T, Niwa K, Zhou P, Ross ME, Iadecola C (2004) Prostanoids, not reactive oxygen species, mediate COX-2\u2013dependent neurotoxicity. Ann Neurol 55(5):668\u2013675","journal-title":"Ann Neurol"},{"issue":"4","key":"2932_CR53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1440-1819.2012.02354.x","volume":"66","author":"RB Mansur","year":"2012","unstructured":"Mansur RB, Zugman A, Asevedo EDM, da Cunha GR, Bressan RA, Brietzke E (2012) Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages. Psychiatry Clin Neurosci 66(4):247\u2013260","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"2932_CR54","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RS, McGuire PK (2023) Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry 28(5):1902\u20131918","journal-title":"Mol Psychiatry"},{"issue":"5","key":"2932_CR55","doi-asserted-by":"publisher","first-page":"e1210","DOI":"10.1542\/peds.2013-1580","volume":"132","author":"C McKeown","year":"2013","unstructured":"McKeown C, Hisle-Gorman E, Eide M, Gorman GH, Nylund CM (2013) Association of constipation and fecal incontinence with attention-deficit\/hyperactivity disorder. Pediatrics 132(5):e1210\u2013e1215","journal-title":"Pediatrics"},{"key":"2932_CR56","first-page":"211","volume":"11","author":"A Menke","year":"2018","unstructured":"Menke A (2018) Precision pharmacotherapy: psychiatry\u2019s future direction in preventing, diagnosing, and treating mental disorders. Pharmacogen Personal Med. 11:211\u2013222","journal-title":"Pharmacogen Personal Med."},{"issue":"1","key":"2932_CR57","doi-asserted-by":"publisher","first-page":"20190016","DOI":"10.1515\/jcim-2019-0016","volume":"17","author":"A Mesripour","year":"2020","unstructured":"Mesripour A, Shahnooshi S, Hajhashemi V (2020) Celecoxib, ibuprofen, and indomethacin alleviate depression-like behavior induced by interferon-alfa in mice. J Complement Integr Med 17(1):20190016","journal-title":"J Complement Integr Med"},{"issue":"8","key":"2932_CR58","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/bph.14167","volume":"176","author":"JA Mitchell","year":"2019","unstructured":"Mitchell JA, Kirkby NS (2019) Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system. Br J Pharmacol 176(8):1038\u20131050","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2932_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiat 74(1):15\u201325","journal-title":"Biol Psychiat"},{"issue":"1","key":"2932_CR60","first-page":"46","volume":"1","author":"D Mohale","year":"2014","unstructured":"Mohale D, Tripathi A, Wahane J, Chandewar A (2014) A pharmacological review on cyclooxygenase enzyme. Ind J Pharm Pharmacol 1(1):46\u201358","journal-title":"Ind J Pharm Pharmacol"},{"issue":"6","key":"2932_CR61","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1089\/cap.2016.0207","volume":"27","author":"SY Mousavi","year":"2017","unstructured":"Mousavi SY, Khezri R, Karkhaneh-Yousefi MA, Mohammadinejad P, Gholamian F, Mohammadi MR, Akhondzadeh S (2017) A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania. J Child Adolesc Psychopharmacol. 27(6):494\u2013500","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"12","key":"2932_CR62","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1080\/14737175.2016.1256206","volume":"16","author":"N M\u00fcller","year":"2016","unstructured":"M\u00fcller N (2016) What role does inflammation play in schizophrenia? Expert Rev Neurother 16(12):1337\u20131340","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"2932_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.31887\/DCNS.2017.19.1\/nmueller","volume":"19","author":"N M\u00fcller","year":"2017","unstructured":"M\u00fcller N (2017) Immunological aspects of the treatment of depression and schizophrenia. Dialogues Clin Neurosci 19(1):55\u201363","journal-title":"Dialogues Clin Neurosci"},{"key":"2932_CR64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fpsyt.2019.00375","volume":"10","author":"N M\u00fcller","year":"2019","unstructured":"M\u00fcller N (2019) COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disorders. Front Psych 10:375","journal-title":"Front Psych"},{"key":"2932_CR02","doi-asserted-by":"crossref","unstructured":"M\u00fcller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Riedel M (2010) Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophrenia Res  121(1\u20133):118\u2013124","DOI":"10.1016\/j.schres.2010.04.015"},{"issue":"8","key":"2932_CR65","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.2174\/138920112800784826","volume":"13","author":"N Muller","year":"2012","unstructured":"Muller N, Myint AM, Schwarz JM (2012) Immunological treatment options for schizophrenia. Curr Pharm Biotechnol 13(8):1606\u20131613","journal-title":"Curr Pharm Biotechnol"},{"issue":"9","key":"2932_CR66","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"K Munkholm","year":"2013","unstructured":"Munkholm K, Bra\u00fcner JV, Kessing LV, Vinberg M (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 47(9):1119\u20131133","journal-title":"J Psychiatr Res."},{"issue":"2","key":"2932_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hup.912","volume":"23","author":"FG Nery","year":"2008","unstructured":"Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, Soares JC (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol Clin Exp 23(2):87\u201394","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"14","key":"2932_CR68","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/jama.2023.18588","volume":"330","author":"AA Nierenberg","year":"2023","unstructured":"Nierenberg AA, Agustini B, K\u00f6hler-Forsberg O, Cusin C, Katz D, Sylvia LG, Berk M (2023) Diagnosis and treatment of bipolar disorder: a review. JAMA 330(14):1370\u20131380","journal-title":"JAMA"},{"key":"2932_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-9081-6-1","volume":"6","author":"RD Oades","year":"2010","unstructured":"Oades RD, Myint AM, Dauvermann MR, Schimmelmann BG, Schwarz MJ (2010) Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behav Brain Funct 6:1\u201319","journal-title":"Behav Brain Funct"},{"issue":"1","key":"2932_CR70","first-page":"1","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Schatzberg AF (2016) Major depressive disorder. Nat Rev Dis Prim 2(1):1\u201320","journal-title":"Nat Rev Dis Prim"},{"key":"2932_CR71","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ejmech.2017.09.066","volume":"141","author":"MG Perrone","year":"2017","unstructured":"Perrone MG, Vitale P, Ferorelli S, Boccarelli A, Coluccia M, Pannunzio A, Scilimati A (2017) Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier. Eur J Med Chem. 141:404\u2013416","journal-title":"Eur J Med Chem."},{"issue":"22","key":"2932_CR72","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.3390\/molecules25225388","volume":"25","author":"MG Perrone","year":"2020","unstructured":"Perrone MG, Centonze A, Miciaccia M, Ferorelli S, Scilimati A (2020) Cyclooxygenase inhibition safety and efficacy in inflammation-based psychiatric disorders. Molecules 25(22):5388","journal-title":"Molecules"},{"issue":"5","key":"2932_CR73","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.clinthera.2015.04.002","volume":"37","author":"AI Petra","year":"2015","unstructured":"Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC (2015) Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37(5):984\u2013995","journal-title":"Clin Ther"},{"key":"2932_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jchromb.2014.03.007","volume":"964","author":"M Puppolo","year":"2014","unstructured":"Puppolo M, Varma D, Jansen SA (2014) A review of analytical methods for eicosanoids in brain tissue. J Chromatogr B 964:50\u201364","journal-title":"J Chromatogr B"},{"issue":"6","key":"2932_CR75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/mp.2008.31","volume":"13","author":"JS Rao","year":"2008","unstructured":"Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry 13(6):585\u2013596","journal-title":"Mol Psychiatry"},{"key":"2932_CR01","unstructured":"Rappard F, M\u00fcller N (2004) Celecoxib add-on therapy does not have beneficial antipsychotic effects over risperidone alone in schizophrenia. In: Neuropsychopharmacology, vol 29. Nature Publishing Group, London, p 222"},{"issue":"1","key":"2932_CR76","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12974-019-1592-3","volume":"16","author":"C Rawat","year":"2019","unstructured":"Rawat C, Kukal S, Dahiya UR, Kukreti R (2019) Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management. J Neuroinflammation 16(1):197","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2932_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14728222.2019.1554056","volume":"23","author":"A Rojas","year":"2019","unstructured":"Rojas A, Chen D, Ganesh T, Varvel NH, Dingledine R (2019) The COX-2\/prostanoid signaling cascades in seizure disorders. Expert Opin Ther Targets 23(1):1\u201313","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"2932_CR78","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/med.22012","volume":"44","author":"K Saleki","year":"2024","unstructured":"Saleki K, Alijanizadeh P, Javanmehr N, Rezaei N (2024) The role of Toll-like receptors in neuropsychiatric disorders: immunopathology, treatment, and management. Med Res Rev 44(3):1267\u20131325","journal-title":"Med Res Rev"},{"issue":"7589","key":"2932_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, De Rivera H, Davis A, Hammond TR, Kamitaki N, McCarroll SA (2016) Schizophrenia risk from complex variation of complement component 4. Nature. 530(7589):177\u2013183","journal-title":"Nature."},{"issue":"9","key":"2932_CR80","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/npp.2012.58","volume":"37","author":"K Sepanjnia","year":"2012","unstructured":"Sepanjnia K, Modabbernia A, Ashrafi M, Modabbernia MJ, Akhondzadeh S (2012) Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial. Neuropsychopharmacology 37(9):2093\u20132100","journal-title":"Neuropsychopharmacology"},{"issue":"42","key":"2932_CR81","doi-asserted-by":"publisher","first-page":"14850","DOI":"10.1523\/JNEUROSCI.3922-11.2011","volume":"31","author":"GE Serrano","year":"2011","unstructured":"Serrano GE, Lelutiu N, Rojas A, Cochi S, Shaw R, Makinson CD, Dingledine R (2011) Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J Neurosci. 31(42):14850\u201314860","journal-title":"J Neurosci."},{"key":"2932_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110373","volume":"129","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kaur A, Singh TG (2020) Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease. Biomed Pharmacother 129:110373","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2932_CR83","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s43440-024-00613-5","volume":"76","author":"V Sharma","year":"2024","unstructured":"Sharma V, Sharma P, Singh TG (2024) Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases. Pharmacol Rep. 76(4):679\u2013692","journal-title":"Pharmacol Rep."},{"issue":"9","key":"2932_CR84","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00702-024-02803-0","volume":"131","author":"V Sharma","year":"2024","unstructured":"Sharma V, Sharma P, Singh TG (2024) Therapeutic potential of transient receptor potential (TRP) channels in psychiatric disorders. J Neural Trans. 131(9):1025\u20131037","journal-title":"J Neural Trans."},{"issue":"1","key":"2932_CR85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11033-023-09202-w","volume":"51","author":"V Sharma","year":"2024","unstructured":"Sharma V, Sharma P, Singh TG (2024c) Wnt signalling pathways as mediators of neuroprotective mechanisms: therapeutic implications in stroke. Mol Biol Rep 51(1):247","journal-title":"Mol Biol Rep"},{"issue":"2","key":"2932_CR86","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10072-024-07802-3","volume":"46","author":"V Sharma","year":"2025","unstructured":"Sharma V, Sharma P, Singh TG (2025) Mechanistic insights on the role of Nrf-2 signalling in Huntington\u2019s disease. Neurol Sci 46(2):593\u2013604","journal-title":"Neurol Sci"},{"issue":"3","key":"2932_CR87","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1124\/jpet.103.063867","volume":"309","author":"JM Silakova","year":"2004","unstructured":"Silakova JM, Hewett JA, Hewett SJ (2004) Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window. J Pharmacol Exp Ther 309(3):1060\u20131066","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"2932_CR88","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1517\/14656566.2014.937704","volume":"15","author":"SD Silberstein","year":"2014","unstructured":"Silberstein SD, Stirpe JC (2014) COX inhibitors for the treatment of migraine. Expert Opin Pharmacother 15(13):1863\u20131874","journal-title":"Expert Opin Pharmacother"},{"key":"2932_CR89","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/B978-0-444-63438-2.00009-2","volume-title":"Biochemistry of lipids, lipoproteins and membranes","author":"WL Smith","year":"2016","unstructured":"Smith WL, Murphy RC (2016) The eicosanoids: cyclooxygenase, lipoxygenase and epoxygenase pathways. Biochemistry of lipids, lipoproteins and membranes. Elsevier, New York, pp 259\u2013296"},{"issue":"9","key":"2932_CR90","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.17219\/acem\/174243","volume":"33","author":"P Soko\u0142owska","year":"2024","unstructured":"Soko\u0142owska P, Bleibel L, Owczarek J, Wiktorowska-Owczarek A (2024) PPAR\u03b3, NF-\u03baB and the UPR pathway as new molecular targets in theanti-inflammatory actions of NSAIDs: Novel applications in cancers and central nervous system diseases? Adv Clin Exp Med 33(9):1007\u20131022","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"2932_CR91","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/schbul\/sbt139","volume":"40","author":"IE Sommer","year":"2014","unstructured":"Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS (2014) Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull 40(1):181\u2013191","journal-title":"Schizophr Bull"},{"key":"2932_CR92","doi-asserted-by":"publisher","first-page":"107779","DOI":"10.1016\/j.neuropharm.2019.107779","volume":"160","author":"Q Song","year":"2019","unstructured":"Song Q, Feng YB, Wang L, Shen J, Li Y, Fan C, Yu SY (2019) COX-2 inhibition rescues depression-like behaviors via suppressing glial activation, oxidative stress and neuronal apoptosis in rats. Neuropharmacology. 160:107779","journal-title":"Neuropharmacology."},{"issue":"1","key":"2932_CR93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neures.2006.06.003","volume":"56","author":"T Takemiya","year":"2006","unstructured":"Takemiya T, Maehara M, Matsumura K, Yasuda S, Sugiura H, Yamagata K (2006) Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neurosci Res 56(1):103\u2013110","journal-title":"Neurosci Res"},{"key":"2932_CR94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jare.2017.11.004","volume":"11","author":"H Tallima","year":"2018","unstructured":"Tallima H, El Ridi R (2018) Arachidonic acid: physiological roles and potential health benefits\u2013a review. J Adv Res 11:33\u201341","journal-title":"J Adv Res"},{"issue":"1","key":"2932_CR95","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT (2012) PAMP s and DAMP s: Signal 0s that spur autophagy and immunity. Immunol Rev 249(1):158\u2013175","journal-title":"Immunol Rev"},{"issue":"10172","key":"2932_CR96","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393(10172):689\u2013701","journal-title":"Lancet"},{"issue":"6","key":"2932_CR97","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2215\/CJN.18501120","volume":"16","author":"EYF Wan","year":"2021","unstructured":"Wan EYF, Yu EYT, Chan L, Mok AHY, Wang Y, Chan EWY, Lam CLK (2021) Comparative risks of nonsteroidal anti-inflammatory drugs on CKD. Clin J Am Soc Nephrol 16(6):898\u2013907","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2932_CR98","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neures.2011.07.1821","volume":"71","author":"F Wang","year":"2011","unstructured":"Wang F, Wu H, Xu S, Guo X, Yang J, Shen X (2011) Macrophage migration inhibitory factor activates cyclooxygenase 2\u2013prostaglandin E2 in cultured spinal microglia. Neurosci Res 71(3):210\u2013218","journal-title":"Neurosci Res"},{"issue":"1","key":"2932_CR99","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Wang DW (2021) Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal transduct Target ther. 6(1):94","journal-title":"Signal transduct Target ther."},{"key":"2932_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174396","volume":"909","author":"J Wang","year":"2021","unstructured":"Wang J, Chen R, Liu C, Wu X, Zhang Y (2021b) Antidepressant mechanism of catalpol: Involvement of the PI3K\/Akt\/Nrf2\/HO-1 signaling pathway in rat hippocampus. Eur J Pharmacol 909:174396","journal-title":"Eur J Pharmacol"},{"key":"2932_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-015-0514-9","volume":"17","author":"BB Weksler","year":"2015","unstructured":"Weksler BB (2015) Prostanoids and NSAIDs in cardiovascular biology and disease. Curr Atheroscler Rep 17:1\u20138","journal-title":"Curr Atheroscler Rep"},{"key":"2932_CR102","unstructured":"Weyns AS (2024) Exploring the therapeutic potential of French maritime pine bark extract in attention-deficit hyperactivity disorder and arterial stiffness (Doctoral dissertation, University of Antwerp)."},{"issue":"10","key":"2932_CR103","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s11064-022-03641-w","volume":"47","author":"X Wu","year":"2022","unstructured":"Wu X, Liu C, Wang J, Guan Y, Song L, Chen R, Gong M (2022) Catalpol exerts antidepressant-like effects by enhancing anti-oxidation and neurotrophy and inhibiting neuroinflammation via activation of HO-1. Neurochem Res 47(10):2975\u20132991","journal-title":"Neurochem Res"},{"issue":"3","key":"2932_CR104","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mito.2012.10.003","volume":"13","author":"H Yin","year":"2013","unstructured":"Yin H, Zhou Y, Zhu M, Hou S, Li Z, Zhong H, Wu Y (2013) Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids. Mitochondrion 13(3):209\u2013224","journal-title":"Mitochondrion"},{"issue":"6","key":"2932_CR105","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2174\/1570159X13666151102103305","volume":"13","author":"K Yui","year":"2015","unstructured":"Yui K, Imataka G, Nakamura H, Ohara N, Naito Y (2015) Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders. Curr Neuropharmacol 13(6):776\u2013785","journal-title":"Curr Neuropharmacol"},{"key":"2932_CR106","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.brainresbull.2021.06.020","volume":"174","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu K, Shi M, Xie L, Deng M, Chen H, Li X (2021) Therapeutic potential of catalpol and geniposide in Alzheimer\u2019s and Parkinson\u2019s diseases: a snapshot of their underlying mechanisms. Brain Res Bull 174:281\u2013295","journal-title":"Brain Res Bull"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-02932-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-02932-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T12:02:28Z","timestamp":1751284948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-02932-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":111,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2932"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-02932-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}